GlassScriptPhysician profile
Russell Benjamin Edwards
NPI 1629305404
$29,081.90
in general payments reported to CMS, 2019-2025
32 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $199 · 2021: $4,650 · 2022: $11K · 2023: $1,618 · 2024: $11K · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,099 · Travel and Lodging: $2,452 · Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,099.00 |
| Travel and Lodging | $2,452.41 |
| Food and Beverage | $1,466.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,810.65 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $369.32 | 2019-2022 | |
| Daiichi Sankyo INC. | $258.65 | 2019-2022 | |
| Astellas Pharma US INC | $220.74 | 2022-2025 | Veozah |
| Shield Therapeutics INC | $208.30 | 2023-2024 | Accrufer |
| Biogen, INC. | $137.75 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $107.04 | 2023 | |
| Roche Diagnostics Corporation | $96.26 | 2019-2020 | |
| Molnlycke Health Care US, LLC | $89.77 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Hologic Sales and Service, LLC | $87.49 | 2023-2024 | Aptima, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Evofem Biosciences, INC. | $82.98 | 2020-2022 | |
| Organon LLC | $78.85 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $70.94 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $47.59 | 2019-2022 | |
| Pfizer INC. | $35.85 | 2023-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $35.79 | 2022-2023 | Slynd |
| Abbott Laboratories | $33.30 | 2025 | Aveir |
| Conmed Corporation | $31.17 | 2025 | Airseal, System 2450 |
| Medicem INC. | $29.92 | 2021-2022 | |
| Medtronic, INC. | $27.86 | 2022 | |
| 180 Medical, INC. | $25.85 | 2021 | |
| Avion Pharmaceuticals | $25.83 | 2019 | |
| Smith+Nephew, INC. | $24.88 | 2023 | Pico 7 |
| Myovant Sciences INC. | $23.77 | 2022 | |
| Heron Therapeutics, INC. | $18.75 | 2022 | |
| Tela Bio, INC. | $17.71 | 2020 | |
| Aspira Women'S Health INC | $17.30 | 2022 | |
| Novo Nordisk INC | $16.78 | 2023 | Wegovy |
| Minerva Surgical, INC | $15.69 | 2025 | |
| Currax Pharmaceuticals LLC | $12.99 | 2023 | Contrave |
| Coopersurgical, INC. | $12.30 | 2022 | |
| Biomerieux INC | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.